POSSIBLE GENE EFFECT OF A MUTANT CARDIAC BETA-MYOSIN HEAVY-CHAIN GENE ON THE CLINICAL EXPRESSION OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY

被引:54
作者
NISHI, H
KIMURA, A
HARADA, H
ADACHI, K
KOGA, Y
SASAZUKI, T
TOSHIMA, H
机构
[1] KYUSHU UNIV,MED INST BIOREGULAT,DEPT GENET,FUKUOKA 812,JAPAN
[2] KURUME UNIV,SCH MED,DEPT INTERNAL MED 3,KURUME,FUKUOKA 830,JAPAN
关键词
D O I
10.1006/bbrc.1994.1483
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have examined for a mutation in the cardiac beta myosin heavy chain gene from Japanese patients with familial hypertrophic cardiomyopathy. A missense mutation due to a G to A transition in codon 935, leading to a replacement of Glu with Lys, was found in one patient. Family members of this patient were then examined. It was revealed that both the proband and his elder brother, who was also a symptomatic patient, were homozygous for the mutation. The proband eventually died of intractable heart failure, and his brother died suddenly in their thirties. On the other hand, his parents, who were first cousins and heterozygous for the mutation, had cardiac hypertrophy without clinical symptoms. His elder sister was also heterozygous for the mutation, however, she did not manifest with cardiac hypertrophy. These observations suggest a gene-dose-like effect of the mutant cardiac beta myosin heavy chain gene on the clinical manifestation of familial hypertrophic cardiomyopathy. (C) 1994 Academic Press, Inc.
引用
收藏
页码:549 / 556
页数:8
相关论文
共 36 条
[1]   FUNCTIONS OF THE MYOSIN ATP AND ACTIN BINDING-SITES ARE REQUIRED FOR C-ELEGANS THICK FILAMENT ASSEMBLY [J].
BEJSOVEC, A ;
ANDERSON, P .
CELL, 1990, 60 (01) :133-140
[2]   MYOSIN HEAVY-CHAIN MUTATIONS THAT DISRUPT CAENORHABDITIS-ELEGANS THICK FILAMENT ASSEMBLY [J].
BEJSOVEC, A ;
ANDERSON, P .
GENES & DEVELOPMENT, 1988, 2 (10) :1307-1317
[3]   SEQUENCE-ANALYSIS OF THE COMPLETE CAENORHABDITIS-ELEGANS MYOSIN HEAVY-CHAIN GENE FAMILY [J].
DIBB, NJ ;
MARUYAMA, IN ;
KRAUSE, M ;
KARN, J .
JOURNAL OF MOLECULAR BIOLOGY, 1989, 205 (03) :603-613
[4]   DIFFERENCES IN CLINICAL EXPRESSION OF HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH 2 DISTINCT MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE - A 908LEU-]VAL MUTATION AND A 403ARG-]GLN MUTATION [J].
EPSTEIN, ND ;
COHN, GM ;
CYRAN, F ;
FANANAPAZIR, L .
CIRCULATION, 1992, 86 (02) :345-352
[5]   EVIDENCE OF GENETIC-HETEROGENEITY IN 5 KINDREDS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
EPSTEIN, ND ;
FANANAPAZIR, L ;
LIN, HJ ;
MULVIHILL, J ;
WHITE, R ;
LALOUEL, JM ;
LIFTON, RP ;
NIENHUIS, AW ;
LEPPERT, M .
CIRCULATION, 1992, 85 (02) :635-647
[6]   GENETIC-EVIDENCE OF DISSOCIATION (GENERATIONAL SKIPS) OF ELECTRICAL FROM MORPHOLOGICAL FORMS OF HYPERTROPHIC CARDIOMYOPATHY [J].
EPSTEIN, ND ;
LIN, HJ ;
FANANAPAZIR, L .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (05) :627-631
[7]   MISSENSE MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE CAUSE CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY [J].
FANANAPAZIR, L ;
DALAKAS, MC ;
CYRAN, F ;
COHN, G ;
EPSTEIN, ND .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :3993-3997
[8]   A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J].
GEISTERFERLOWRANCE, AAT ;
KASS, S ;
TANIGAWA, G ;
VOSBERG, HP ;
MCKENNA, W ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1990, 62 (05) :999-1006
[9]  
GOLDSTEIN JL, 1989, METABOLIC BASIS INHE, V1, P1215
[10]  
GOODWIN JF, 1970, LANCET, V1, P731